BioStrand is a biotech startup that is advancing technology for analyzing genetic data.
BioStrand is on a mission to make genomic analysis available for everyone.
BioStrand was founded in February 2019 by Dirk van Hyfte and Ingrid Brands. The company is headquartered in Diepenbeek, Flemish Region, Belgium.
BioStrand offers a revolutionary methodology for genomic variation identification that will boost evolutions in precision medicine, drug development and agriculture.
BioStrand is the first since the Eighties to come up with a completely new and out of the box solution for genetic data analysis. Where next generation sequencing revolutionized sequence data generation in the last decade, BioStrand now revolutionizes sequence data analysis. With our fundamentally new method we make sure that genomic data analysis finally can keep pace with genetic data generation.
BioStrand has raised €2M in Seed funding on June 08, 2020. The investment was backed by K-E.